[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Micro and Nano Technologies for Point-of-Care Testing

February 2013 | | ID: M5A3DB95E86EN
Venture Planning Group

US$ 3,040.00 US$ 3,800.00 -20 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Introduction

Micro and nanotechnologies are set to transform point-of-care diagnostics. Miniaturization of testing methods, advances in lab-on-a-chip microfluidic methodologies, improvements in detection technologies and novel biosensors are leading the way.

Features and benefits
  • Identify micro and nanotechnologies driving the development of next-generation point-of-care diagnostics to benefit from opportunities being created.
  • Discover which analytes/diseases are currently being targeted by profiled companies to formulate your own diagnostic product development strategies.
  • Assess the evolving POC testing market with the aid of market forecasts for individual market segments to prepare for future growth in this area.
  • Forecast key point-of-care testing market segments to 2016.
Highlights

Various proprietary technologies identified in this report underpin POC testing products in development. These technologies represent valid alternative approaches to challenges such as multiplexing, liquid transport in miniaturized systems, integration of assay procedures, and limitations associated with the use of traditional fluorescent labels.

The microfluidic lab-on-a-chip (LoC) is now firmly established as an attractive miniaturized platform for POC testing. Maturing of LoC technologies is stimulating efforts to incorporate miniaturized biosensors into portable LoC systems to accelerate the development of portable and handheld testing systems

Most of the products discussed in this report are being developed for healthcare professional-based testing. Four professional-based POCT market sectors - infectious disease; cardiac marker; coagulation (including pharmacogenomics); and cancer screening/pharmacogenomics - are forecast to grow at CAGRs of 14%, 22%, 19% and 30% respectively.

Your key questions answered
  • Which micro and nano technologies in development offer the attributes of miniat
  • What drivers and restraints operate in the nascent market for POC testing products based on micro and nanotechnologies?
  • Who is developing new POC testing products based on micro and nanotechnologies and which clinical applications are they targeting?
  • How will POC testing products based on micro and nanotechnologies impact areas inadequately served by current products and areas of unmet need?
  • What are the estimated current market sizes and 5-year growth forecasts for the sectors of the POC testing market currently targeted?
EXECUTIVE SUMMARY

Key findings
  The effects of evolving diagnostic technologies

CURRENT POCT TECHNOLOGIES AND APPLICATIONS

Summary
Introduction
Enabling IVDT technologies
  Immunoassays
  Probe-based nucleic acid testing
  Mass spectrometry
Regulation of IVDs
Current POCT systems
  Multi-channel immunoanalyzers
Micro- and nanotechnologies for POCT

MICRO- AND NANOARRAYS

Summary
Introduction
Developments in DNA microarrays
  High density microarrays
  Low or medium density microarrays
  Microarray platforms
Developments in protein microarrays
Focus on detection technologies
  Label-based technologies
  Label-free technologies
Innovations in nanoarrays
  Nanofabrication techniques
  Applications

MICROFLUIDICS ‐ BASED LOC SYSTEMS

Summary
Mirofluidic devices and technologies
Microfluidic NAT systems
  Integrated LoC commercial systems
Microfluidic immunoassays
  Substrate materials for microfluidic immunoassays
  Immobilization methods for immunoassays
Liquid transport control strategies
  Micropneumatic pumping
  Multilayer soft lithography
  Centrifugal force
  Phaseguide technology
  Electrokinetics
  Electrowetting
  Other approaches
Detection methods
  Optical detection using labels
  Non-optical label-free technologies

ADVANCES IN BIOSENSORS

Summary
Introduction
Advances in optical detection
  Signal intensification technologies
  Optical fiber technology
  Electrochemical sensors
Piezoelectric sensors
Nanomaterial-based biosensors
  Challenge of non-specific protein adsorption
Nanoparticles for sensor devices
  Quantum dots and gold nanoparticles
  Magnetic nanoparticles
  Nanoelectrodes
  Nanotubes
  Nanowires
Nanopore sensors
  Biological nanopores
  Solid-state and hybrid nanopores
Artificial olfaction sensors
Other sensors

COMPANY PROFILES

Introduction
Advanced Liquid Logic
  Overview of company business
  Proprietary micro/nanotechnologies
  POCT products
  Recent POCT-related collaborations
Akonni Biosystems
  Overview of company business
  Proprietary micro/nanotechnologies
  POCT products
  Recent POCT-related collaborations
Applied Nanodetectors
  Overview of company business
  Proprietary micro/nanotechnologies
  POCT products
Aquila Diagnostic Systems
  Overview of company business
  Proprietary micro/nanotechnologies
  POCT products
ArcDia International
  Overview of company business
  Proprietary micro/nanotechnologies
  POCT products
BioCartis
  Overview of company business
  Proprietary micro/nanotechnologies
  Recent POCT-related collaborations
BioForce Nanosciences
  Overview of company business
  Proprietary micro/nanotechnologies
  POCT products
Bio-Rad Laboratories
  Company description
  Proprietary micro/nanotechnologies (acquired from QuantaLife)
  POCT products
Biosurfit
  Overview of company business
  Proprietary micro/nanotechnologies
  POCT products
Biosystems International
  Overview of company business
  Proprietary micro/nanotechnologies
  POCT products
  Recent POCT-related collaborations
Cambridge Biomagnetics
  Overview of company business
  Proprietary micro/nanotechnologies
  POCT products
DNA Electronics
  Overview of company business
  Proprietary micro/nanotechnologies
  POCT products
  Recent POCT-related collaborations
Epocal
  Overview of company business
  Proprietary micro/nanotechnologies
  POCT products
  Recent POCT-related collaborations
Fluidigm
  Overview of company business
  Proprietary micro/nanotechnologies
FluimediX
  Overview of company business
  Proprietary micro/nanotechnologies
  POCT products
Fluigent
  Overview of company business
  Proprietary micro/nanotechnologies
GenMark Diagnostics
  Overview of company business
  Proprietary micro/nanotechnologies
  POCT products
Integrated Nano-Technologies
  Overview of company business
  Proprietary micro/nanotechnologies
  POCT products
Kumetrix
  Overview of company business
  Proprietary micro/nanotechnologies
  POCT products
Luminex Corporation
  Overview of company business
  Proprietary micro/nanotechnologies
  POCT products
MagArray
  Overview of company business
  Proprietary micro/nanotechnologies
  POCT products
Micronics
  Overview of company business
  Proprietary micro/nanotechnologies
  POCT products
Molecular Vision
  Overview of company business
  Proprietary micro/nanotechnologies
  POCT products
NanoIVD
  Overview of company business
  Proprietary micro/nanotechnologies
  POCT products
Nanomix
  Overview of company business
  Proprietary micro/nanotechnologies
  POCT products
Nanosphere
  Overview of company business
  Proprietary micro/nanotechnologies
  POCT products
NVE Corporation
  Overview of company business
  Proprietary micro/nanotechnologies
  POCT products
OJ-Bio
  Overview of company business
  Proprietary micro/nanotechnologies
  POCT products
Oxford Nanopore Technologies
  Overview of company business
  Proprietary micro/nanotechnologies
  POCT products
  Recent POCT-related collaborations
PLC Diagnostics
  Overview of company business
  Proprietary micro/nanotechnologies
  POCT products
Royal Philips Electronics
  Overview of company business
  Proprietary micro/nanotechnologies
  POCT products
  Recent POCT-related collaborations
PLC Diagnostics
  Overview of company business
  Proprietary micro/nanotechnologies
  POCT products
Sirigen
  Overview of company business
  Proprietary micro/nanotechnologies
  POCT products
T2 Biosystems
  Overview of company business
  Proprietary micro/nanotechnologies
  POCT products
TIRF Technologies
  Overview of company business
  Proprietary micro/nanotechnologies
  POCT products
Vivacta
  Overview of company business
  Proprietary micro/nanotechnologies
  POCT products

MARKET TRENDS AND FORECASTS

Summary
Technologies poised t-transform POCT
  The future: early treatment and prevention
Characteristics of the IVD industry
Challenges for developers of novel POCT products
POCT market forecasts by selected application
  Infectious disease testing
  Cardiac marker testing
  Coagulation testing and pharmacogenomics
  Cancer screening and pharmacogenomics

APPENDIX

Contributors
  Managing analyst
Scope
Methodology
Glossary/abbreviations
Bibliography/references
  Websites of companies mentioned in this report
Disclaimer

TABLES

Table: Selected companies developing microfluidic POC lab-on-a-chip systems
Table: Selected companies developing biosensors for POCT applications
Table: Global POCT market forecasts by reviewed segment, 2011–16

FIGURES

Figure: Schematic of a typical lateral flow device
Figure: Customizable features of the ESE-Quant lateral flow system
Figure: Akonni Systems’ TruArray gel microarray
Figure: PLC Diagnostics’ In-plane parallel scanning
Figure: A typical lab-on-a-chip for POC testing with associated instrumentation
Figure: PCR analysis on Advanced Liquid Logic’s electrowetting chip
Figure: Schematic of a lab-on-a-chip for fluorescence analysis
Figure: Molecular Vision's polymer detection system and credit card-sized LoC device
Figure: GenMark Diagnostics’ eSensor technology
Figure: NVE Corporation’s spintronic sensor
Figure: Schematic of a Surface Generated Acoustic Wave (SGAW) sensor


More Publications